In September 2022, former President Biden convened the White House Conference on Hunger, Nutrition, and Health, during which ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...
U.S. attorneys general urge the FDA to combat counterfeit versions of weight loss drugs developed by Eli Lilly (LLY) and Novo ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Scientists comment on a press release from EDX that gives findings on a new screening test for prostate cancer. Prof Veeru Kasivisvanathan, Associate Professor of Urology, University College London, ...
According to EDX, the test studies the most comprehensive range of clinically validated prostate-related biomarkers currently ...
Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback